Skip to main content

Terazosin

NDC 50090-2623 · A-S Medication Solutions

Generic nameTerazosin Hydrochloride
Dosage formCAPSULE
RouteORAL
Active ingredient(s)TERAZOSIN HYDROCHLORIDE
Strength2 mg/1
Pharmacologic classAdrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
Marketing categoryANDA

Packages

50090-2623-0 — 30 CAPSULE in 1 BOTTLE (50090-2623-0)

50090-2623-1 — 90 CAPSULE in 1 BOTTLE (50090-2623-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

27241-288 — Terazosin, 27241-289 — Terazosin, 27241-290 — Terazosin, 27241-291 — Terazosin, 42291-820 — Terazosin Hydrochloride, 42291-821 — Terazosin Hydrochloride, 42291-822 — Terazosin Hydrochloride, 42291-823 — Terazosin Hydrochloride, 50090-0657 — Terazosin Hydrochloride, 50090-2371 — Terazosin Hydrochloride, 50090-7851 — terazosin, 50268-764 — Terazosin Hydrochloride, 50268-765 — Terazosin Hydrochloride, 50268-766 — Terazosin Hydrochloride, 50268-767 — Terazosin Hydrochloride, 51655-915 — terazosin, 53401-022 — terazosin, 59746-383 — Terazosin Hydrochloride, 59746-384 — Terazosin Hydrochloride, 59746-385 — Terazosin Hydrochloride, +62 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels